Combination investigation expanding trifluridine-tipiracil's clinical frontier — the systematic clinical investigation of trifluridine-tipiracil in combinations with immunotherapy (pembrolizumab, nivolumab), targeted therapy (ramucirumab, bevacizumab — validated), PARP inhibitors, and novel agents representing the research pipeline that could substantially expand...